Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies

Rheumatology (Oxford). 2007 May;46(5):842-5. doi: 10.1093/rheumatology/kel435. Epub 2007 Jan 25.

Abstract

Objectives: The clinical and laboratory characteristics of seven patients with anti-aminoacyl-tRNA synthetase (ARS) autoantibodies, specifically anti-OJ (anti-isoleucyl-tRNA synthetase), were examined and compared with previously published findings.

Methods: Serum samples from 1135 Japanese patients with various autoimmune diseases and 48 normal individuals were screened for anti-OJ antibodies using RNA and protein immunoprecipitation assays. The patients whose sera contained anti-OJ antibodies were assessed regarding clinical symptoms, clinical course, laboratory findings, chest radiography and chest computed tomography.

Results: Sera from seven patients were found to contain anti-OJ antibodies. These autoantibodies were associated with interstitial lung disease (ILD) and myositis. The diagnoses of the seven patients were idiopathic interstitial pneumonias (IIPs) in three, polymyositis (PM) in three and PM-rheumatoid arthritis (RA) overlap in the remaining one. All patients had ILD, but muscle weakness and polyarthritis were seen only in four. Raynaud's phenomenon and sclerodactyly were absent in all patients.

Conclusions: These results indicate that the presence of anti-OJ autoantibodies may distinguish a subtype of anti-ARS syndrome that is more closely associated with ILD than myositis or Raynaud's phenomenon.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Antibodies, Antinuclear / blood
  • Arthritis, Rheumatoid / immunology
  • Autoantibodies / blood*
  • Autoimmune Diseases / immunology*
  • Female
  • Humans
  • Immunoprecipitation / methods
  • Isoleucine-tRNA Ligase / immunology*
  • Lung Diseases, Interstitial / immunology
  • Male
  • Middle Aged
  • Polymyositis / immunology
  • Retrospective Studies

Substances

  • Antibodies, Antinuclear
  • Autoantibodies
  • Jo-1 antibody
  • Isoleucine-tRNA Ligase